Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001393254 | SCV001594914 | likely benign | Tuberous sclerosis 2 | 2024-04-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003298639 | SCV004001427 | likely benign | Hereditary cancer-predisposing syndrome | 2023-06-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003394028 | SCV004133802 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
All of Us Research Program, |
RCV004006860 | SCV004826454 | likely benign | Tuberous sclerosis syndrome | 2023-08-15 | criteria provided, single submitter | clinical testing |